Journals Library


HTA - 06/27/01

Use of classical and novel biomarkers as prognostic risk factors for prostate cancer

Project title: Use of classical and novel biomarkers as prognostic risk factors for prostate cancer

Call to action: 06/27 Predicting prognosis in early prostate cancer

Research type: Evidence Synthesis

Chief investigator: Dr Paul SutcliffeORCID logoorcid.org/0000-0003-4198-4678

Lead Author: Dr Paul SutcliffeORCID logoorcid.org/0000-0003-4198-4678

Contractor: The University of Sheffield

Co-investigators: Ms Andrea Shippam, Ms Silvia Hummel.

Started: November 2006 | Status: Published January 2009

Study found that prostate-specific antigen velocity has prognostic value in localised prostate cancer but that further research is needed to provide stronger evidence for the most promising prognostic markers for this type of cancer

Links to project documentation

The links and documents below are related to this research and are added as and when they are produced over the life of the project. The information is provided by the researchers and some may have undergone varying editorial, production and publication models, which differ to NIHR Journals Library reports. Links are to both internal (NIHR) and external websites – the NIHR is not responsible for the content of external websites.

Background & Research Questions

Why the research is being done and what is being asked

Methods

How the research is being done

Publications & Outputs

What the research produced

Outcomes & Impact

What happened as a result of the research

If you would like to receive a notification when this project is updated, please submit your email address below. This will also notify you when the Journals Library report is published.